Abstract
The influence of age, virus dose, lot, and γ-globulin administration on serologic and clinical responses to Jeryl Lynn strain live attenuated mumps virus vaccine was studied. Fever or other clinical reaction referable to the vaccine did not develop in childen given vaccine subcutaneously or by jet gun. Mumps antibody of maternal origin suppressed the serologic response to the vaccine. Replicate lots of vaccine gave equally acceptable performance in children. Three hundred seventeen tissue culture doses of mumps vaccine virus were sufficient to immunize. Up to 100 units of mumps neutralizing antibody in human immune globulin coadministered with vaccine but given into the opposite arm did not suppress serologic response to the vaccine. The vaccine was stable for at least one year in dried form and for at least eight hours at 4 C following rehydration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
